Skip to content
10-Q

Quarterly Report

Terns Pharmaceuticals, Inc.

0000950170-25-103124

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 87.51M sh
Shares Diluted Q2 2025 · Jun 30, 2025 91.58M sh
Shares Diluted Q2 2025 · Jun 30, 2025 91.52M sh
Shares Diluted Q2 2025 · Jun 30, 2024 74.46M sh
Shares Diluted Q2 2025 · Jun 30, 2024 74.43M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $42K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$43.32M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$38.98M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $145.97M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $161.44M
Stockholders Equity Q2 2025 · Jun 30, 2025 $305.23M
Stockholders Equity Q2 2025 · Mar 31, 2025 $326.04M
Stockholders Equity Q2 2025 · Dec 31, 2024 $345.87M
Stockholders Equity Q2 2025 · Jun 30, 2024 $218.68M
Stockholders Equity Q2 2025 · Mar 31, 2024 $236.72M
Stockholders Equity Q2 2025 · Dec 31, 2023 $255.37M
Current Liabilities Q2 2025 · Jun 30, 2025 $12.91M
Current Liabilities Q2 2025 · Dec 31, 2024 $15.65M
Total Liabilities Q2 2025 · Jun 30, 2025 $15.19M
Total Liabilities Q2 2025 · Dec 31, 2024 $18.06M
Current Assets Q2 2025 · Jun 30, 2025 $318.95M
Current Assets Q2 2025 · Dec 31, 2024 $362.11M
Total Assets Q2 2025 · Jun 30, 2025 $320.42M
Total Assets Q2 2025 · Dec 31, 2024 $363.93M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.26
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.52
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.31
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.61
Eps Basic Q2 2025 · Jun 30, 2025 −$0.26
Eps Basic Q2 2025 · Jun 30, 2025 −$0.52
Eps Basic Q2 2025 · Jun 30, 2024 −$0.31
Eps Basic Q2 2025 · Jun 30, 2024 −$0.61
Sga Expense Q2 2025 · Jun 30, 2025 $7.03M
Sga Expense Q2 2025 · Jun 30, 2025 $15.74M
Sga Expense Q2 2025 · Jun 30, 2024 $7.19M
Sga Expense Q2 2025 · Jun 30, 2024 $14.04M
Net Income Q2 2025 · Jun 30, 2025 −$24.09M
Net Income Q2 2025 · Mar 31, 2025 −$23.91M
Net Income Q2 2025 · Jun 30, 2024 −$22.74M
Net Income Q2 2025 · Mar 31, 2024 −$22.37M
Operating Income Q2 2025 · Jun 30, 2025 −$27.38M
Operating Income Q2 2025 · Jun 30, 2025 −$54.81M
Operating Income Q2 2025 · Jun 30, 2024 −$25.54M
Operating Income Q2 2025 · Jun 30, 2024 −$50.98M